Cargando…
Risk for primary cephalosporin resistance in Gram-negative bacteremia
OBJECTIVE: This study aimed to examine the clinical risk factors for cephalosporin resistance in patients with Gram-negative bacteremia caused by Escherichia coli (EC), Klebsiella pneumoniae (KP), Enterobacter cloacae (ENC), and Pseudomonas aeruginosa (PS). METHODS: This retrospective cohort study i...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369432/ https://www.ncbi.nlm.nih.gov/pubmed/37502246 http://dx.doi.org/10.1017/ash.2023.202 |
_version_ | 1785077759590006784 |
---|---|
author | John, Princy Shahbazian, Sona Lainhart, William D. Hayes, Justin Mochon, Brian Nix, David E. |
author_facet | John, Princy Shahbazian, Sona Lainhart, William D. Hayes, Justin Mochon, Brian Nix, David E. |
author_sort | John, Princy |
collection | PubMed |
description | OBJECTIVE: This study aimed to examine the clinical risk factors for cephalosporin resistance in patients with Gram-negative bacteremia caused by Escherichia coli (EC), Klebsiella pneumoniae (KP), Enterobacter cloacae (ENC), and Pseudomonas aeruginosa (PS). METHODS: This retrospective cohort study included 400 adults with Gram-negative bacteremia. The goal was to review 100 cases involving each species and approximately half resistant and half susceptible to first-line cephalosporins, ceftriaxone (EC or KP), or cefepime (ENC or PS). Logistic regression was used to identify factors predictive of resistance. RESULTS: A total of 378 cases of Gram-negative bacteremia were included in the analysis. Multivariate analysis identified significant risk factors for resistance, including admission from a chronic care hospital, skilled nursing facility, or having a history of infection within the prior 6 months (OR 3.00, P < .0001), requirement for mechanical ventilation (OR 3.76, P < .0001), presence of hemiplegia (OR 3.54, P = .0304), and presence of a connective tissue disease (OR 3.77, P = .0291). CONCLUSIONS: Patients without the identified risk factors should be strongly considered for receiving ceftriaxone or cefepime rather than carbapenems and newer broad-spectrum agents. |
format | Online Article Text |
id | pubmed-10369432 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-103694322023-07-27 Risk for primary cephalosporin resistance in Gram-negative bacteremia John, Princy Shahbazian, Sona Lainhart, William D. Hayes, Justin Mochon, Brian Nix, David E. Antimicrob Steward Healthc Epidemiol Original Article OBJECTIVE: This study aimed to examine the clinical risk factors for cephalosporin resistance in patients with Gram-negative bacteremia caused by Escherichia coli (EC), Klebsiella pneumoniae (KP), Enterobacter cloacae (ENC), and Pseudomonas aeruginosa (PS). METHODS: This retrospective cohort study included 400 adults with Gram-negative bacteremia. The goal was to review 100 cases involving each species and approximately half resistant and half susceptible to first-line cephalosporins, ceftriaxone (EC or KP), or cefepime (ENC or PS). Logistic regression was used to identify factors predictive of resistance. RESULTS: A total of 378 cases of Gram-negative bacteremia were included in the analysis. Multivariate analysis identified significant risk factors for resistance, including admission from a chronic care hospital, skilled nursing facility, or having a history of infection within the prior 6 months (OR 3.00, P < .0001), requirement for mechanical ventilation (OR 3.76, P < .0001), presence of hemiplegia (OR 3.54, P = .0304), and presence of a connective tissue disease (OR 3.77, P = .0291). CONCLUSIONS: Patients without the identified risk factors should be strongly considered for receiving ceftriaxone or cefepime rather than carbapenems and newer broad-spectrum agents. Cambridge University Press 2023-07-10 /pmc/articles/PMC10369432/ /pubmed/37502246 http://dx.doi.org/10.1017/ash.2023.202 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
spellingShingle | Original Article John, Princy Shahbazian, Sona Lainhart, William D. Hayes, Justin Mochon, Brian Nix, David E. Risk for primary cephalosporin resistance in Gram-negative bacteremia |
title | Risk for primary cephalosporin resistance in Gram-negative bacteremia |
title_full | Risk for primary cephalosporin resistance in Gram-negative bacteremia |
title_fullStr | Risk for primary cephalosporin resistance in Gram-negative bacteremia |
title_full_unstemmed | Risk for primary cephalosporin resistance in Gram-negative bacteremia |
title_short | Risk for primary cephalosporin resistance in Gram-negative bacteremia |
title_sort | risk for primary cephalosporin resistance in gram-negative bacteremia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369432/ https://www.ncbi.nlm.nih.gov/pubmed/37502246 http://dx.doi.org/10.1017/ash.2023.202 |
work_keys_str_mv | AT johnprincy riskforprimarycephalosporinresistanceingramnegativebacteremia AT shahbaziansona riskforprimarycephalosporinresistanceingramnegativebacteremia AT lainhartwilliamd riskforprimarycephalosporinresistanceingramnegativebacteremia AT hayesjustin riskforprimarycephalosporinresistanceingramnegativebacteremia AT mochonbrian riskforprimarycephalosporinresistanceingramnegativebacteremia AT nixdavide riskforprimarycephalosporinresistanceingramnegativebacteremia |